Ardelyx reported $587.52M in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Abbott USD 108.25B 968M Sep/2026
Amgen USD 96.05B 409M Sep/2026
Ardelyx USD 587.52M 11.63M Sep/2026
aTyr Pharma USD 59.81M 10.02M Sep/2026
Corcept Therapeutics USD 1.03B 145.32M Sep/2026
Curis USD 29.69M 9.72M Mar/2026
Sanofi EUR 129.06B 1.04B Jun/2026
TG Therapeutics USD 1.64B 110.79M Jun/2026
United Therapeutics USD 7.03B 186M Sep/2026